EUVIMEDEUVIMED entdecken
Crossref

Urolithin A alleviates radiation pneumonitis by activating PINK1/PRKN-mediated Mitophagy

Anqi Zhang, Shilan Luo, Peng Li, Lu Meng, Litang Huang, Hongxia Cheng, Chenhui Zhao, Hongbin Tu, Xiaomei Gong

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Anqi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Protein Kinases, Radiation Pneumonitis, Coumarins, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Human Resources and Social Security Bureau, Tongji University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Radiation pneumonitis (RP) is a common and severe complication of radiotherapy, whose pathogenesis involves complex inflammatory responses and cellular damage. Despite its clinical significance, effective treatments remain limited. This study investigates the role of radiation-induced PINK1/PRKN-mediated mitophagy and type I interferon responses in RP and evaluates the therapeutic potential of Urolithin A (UA) in regulating inflammation through mitophagy activation. METHODS: We established RP mouse models (20 Gy thoracic irradiation) and radiation-induced BEAS-2B cell models (6 Gy). We systematically investigated mitochondrial damage, mtRNA release, RIG-I/MDA5-MAVS pathway activation, and PINK1/PRKN-mediated mitophagy changes. Moreover, the effects of UA and the mitophagy inhibitor Mdivi-1 on inflammation and lung injury were analyzed. RESULTS: Radiation significantly caused mitochondrial damage in lung tissues, inducing mtRNA release and RIG-I/MDA5-MAVS-mediated type I interferon response. PINK1/PRKN-mediated mitophagy was significantly enhanced, clearing damaged mitochondria and reducing cytosolic mtRNA release, thereby suppressing inflammation. Pharmacological activation of mitophagy with UA markedly improved lung pathology, reduced inflammatory cytokine levels, and inhibited excessive activation of the RIG-I/MDA5-MAVS pathway. Conversely, the knockdown of PINK1 or PRKN weakened the protective effects of UA. Both in vitro and in vivo, UA reduced radiation-induced inflammation and improved lung tissue structure and function through mitophagy. CONCLUSIONS: Radiation-induced mtRNA release activates the RIG-I/MDA5-MAVS-mediated type I interferon response, driving inflammation in RP. PINK1/PRKN-mediated mitophagy significantly alleviates inflammation by reducing cytosolic mtRNA release. As a mitophagy inducer, UA demonstrates therapeutic potential for RP, providing a new direction for the development of anti-inflammatory strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein KinasesRadiation PneumonitisCoumarinsUbiquitin-Protein LigasesAnti-Inflammatory AgentsAnimalsMitophagyHumansMiceMitochondriaCell LineMice, Inbred C57BLMaleLungDisease Models, AnimalSignal TransductionPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

InflammationMitophagyPINK1/PRKNRadiation pneumonitisUrolithin A

Substanzen

Protein KinasesCoumarinsUbiquitin-Protein LigasesAnti-Inflammatory AgentsPTEN-Induced Putative Kinase3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneparkin protein

Autor:innen und Institutionen

  • Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Integrated TCM & Western Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Electronic address: gongxiaomei1981@163.com.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Human Resources and Social Security Bureau
  • Tongji University
  • Tongji University Affiliated Shanghai Pulmonary Hospital

Zitieren

APA

Zhang, A., Luo, S., Li, P., Meng, L., Huang, L., Cheng, H., Zhao, C., Tu, H., & Gong, X. (2025). Urolithin A alleviates radiation pneumonitis by activating PINK1/PRKN-mediated Mitophagy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114671

Vancouver

Zhang A, Luo S, Li P, Meng L, Huang L, Cheng H, et al. Urolithin A alleviates radiation pneumonitis by activating PINK1/PRKN-mediated Mitophagy. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114671

BibTeX
@article{Zhang2025,
  author = {Zhang, Anqi and Luo, Shilan and Li, Peng and Meng, Lu and Huang, Litang and Cheng, Hongxia and Zhao, Chenhui and Tu, Hongbin and Gong, Xiaomei},
  title = {Urolithin A alleviates radiation pneumonitis by activating PINK1/PRKN-mediated Mitophagy},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114671}
}
Kostenlos starten →